Anti-VEGF Use in Ophthalmology: A Comprehensive Guide

Since the introduction of anti-vascular endothelial growth factor (VEGF) agents, the treatment of ocular diseases has undergone a significant transformation. These innovative medications have revolutionized the management of various eye conditions associated with leakage from normal blood vessels and pathologic blood vessel growth.

A Comprehensive Reference for Eye Care Providers

Edited by renowned experts Drs. Jay S. Duker and Michelle C. Liang, Anti-VEGF Use in Ophthalmology is an all-encompassing reference that provides detailed, up-to-date, and clinically relevant information on the use of anti-VEGF agents in treating a wide range of ocular conditions.

This authoritative book is divided into two sections. The first section delves into the history of VEGF, provides an overview of anti-VEGF agents, and explores different routes of drug delivery. This section is essential for eye care providers to stay updated on the latest aspects of these medications and their indications for use.

Clinical Applications of Anti-VEGF Agents

The second section of the book focuses on the clinical uses of anti-VEGF agents in various ocular diseases, including corneal and glaucoma diseases in the anterior segment, uveitis, and retinal and choroidal diseases. Each chapter presents a concise summary of the disease process, accompanied by high-quality ocular imaging to demonstrate the therapeutic use of anti-VEGF agents.

With contributions from a prestigious group of experts in the field, Anti-VEGF Use in Ophthalmology serves as an invaluable resource for eye care providers seeking to stay abreast of the latest developments in anti-VEGF therapy.

Publication Details:

• Publisher: SLACK Incorporated
• Publication Date: May 1, 2017
• Language: English
• ISBN: 9781630913212 (Hardcover), 9781630913229 (eBook)